CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.6070
18.42%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.0360
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.357
Open* 1.447
1-Year Change* 11.66%
Day's Range* 1.377 - 1.927
52 wk Range 0.58-1.71
Average Volume (10 days) 38.21K
Average Volume (3 months) 883.36K
Market Cap 5.55M
P/E Ratio -100.00K
Shares Outstanding 9.40M
Revenue 125.00K
EPS -3.17
Dividend (Yield %) N/A
Beta 1.70
Next Earnings Date Mar 28, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 1.6070 0.1100 7.35% 1.4970 1.9870 1.3770
Mar 27, 2024 1.3570 0.1800 15.29% 1.1770 1.3970 1.1070
Mar 26, 2024 1.1270 0.2140 23.44% 0.9130 1.1670 0.9033
Mar 25, 2024 0.8969 0.0449 5.27% 0.8520 0.8969 0.8520
Mar 22, 2024 0.8744 0.0774 9.71% 0.7970 0.8744 0.7970
Mar 21, 2024 0.8271 0.0374 4.74% 0.7897 0.8362 0.7897
Mar 20, 2024 0.7770 0.0099 1.29% 0.7671 0.7895 0.7670
Mar 19, 2024 0.8030 0.0260 3.35% 0.7770 0.8030 0.7600
Mar 18, 2024 0.8270 -0.0205 -2.42% 0.8475 0.8475 0.7624
Mar 15, 2024 0.7970 -0.0300 -3.63% 0.8270 0.8370 0.7970
Mar 14, 2024 0.7969 -0.0361 -4.33% 0.8330 0.8370 0.7969
Mar 13, 2024 0.8669 -0.0341 -3.78% 0.9010 0.9119 0.8070
Mar 12, 2024 0.9070 -0.0300 -3.20% 0.9370 0.9370 0.8952
Mar 11, 2024 0.9807 0.0641 6.99% 0.9166 0.9870 0.9166
Mar 8, 2024 0.9670 -0.0100 -1.02% 0.9770 0.9770 0.9391
Mar 7, 2024 0.9580 0.0410 4.47% 0.9170 0.9770 0.9170
Mar 6, 2024 0.9491 0.0720 8.21% 0.8771 0.9802 0.8771
Mar 5, 2024 0.8870 -0.0800 -8.27% 0.9670 0.9670 0.8771
Mar 4, 2024 0.9750 -0.1250 -11.36% 1.1000 1.1200 0.9524
Mar 1, 2024 0.9900 -0.1900 -16.10% 1.1800 1.1800 0.9863

Imunon Inc Events

Time (UTC) Country Event
Thursday, May 9, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Imunon Inc Earnings Release
Q1 2024 Imunon Inc Earnings Release

Forecast

-

Previous

-
Thursday, June 13, 2024

Time (UTC)

14:00

Country

US

Event

Imunon Inc Annual Shareholders Meeting
Imunon Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0.5 0.5 0.5 0.5 0.5
Revenue 0.5 0.5 0.5 0.5 0.5
Total Operating Expense 38.7878 23.7177 21.3567 21.0655 26.075
Selling/General/Admin. Expenses, Total 13.6879 10.8879 7.64159 8.00016 9.69952
Research & Development 11.7337 10.6193 11.3448 13.0653 11.8655
Unusual Expense (Income) 13.3662 2.21052 2.37026 0 4.51
Operating Income -38.2878 -23.2177 -20.8567 -20.5655 -25.575
Interest Income (Expense), Net Non-Operating -4.57526 -0.55888 -1.17243 -1.29252 -0.39041
Other, Net 5.3978 1.6239 -1.30028 3.18998 3.66298
Net Income Before Taxes -37.4653 -22.1527 -23.3294 -18.668 -22.3025
Net Income After Taxes -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Net Income Before Extra. Items -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Net Income -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Income Available to Common Excl. Extra. Items -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Income Available to Common Incl. Extra. Items -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Diluted Net Income -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Diluted Weighted Average Shares 7.14297 5.42695 2.13086 1.4556 1.17225
Diluted EPS Excluding Extraordinary Items -5.02567 -3.82706 -10.0821 -11.577 -10.1372
Diluted Normalized EPS -3.15443 -3.43485 -8.96978 -11.577 -6.28992
Total Adjustments to Net Income 0
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0.125 0.125 0.125
Revenue 0 0 0.125 0.125 0.125
Total Operating Expense 5.80344 5.68445 20.418 6.29957 6.10327
Selling/General/Admin. Expenses, Total 2.33989 3.06465 4.04848 3.89089 2.87698
Research & Development 3.1344 2.61981 3.00327 2.40868 3.2263
Unusual Expense (Income) 0.32916 13.3662 0
Operating Income -5.80344 -5.68445 -20.293 -6.17457 -5.97827
Interest Income (Expense), Net Non-Operating 0.24457 0.09308 0.09729 0.02627 -0.06466
Other, Net 0 0 5.396 0 0
Net Income Before Taxes -5.55887 -5.59137 -14.7997 -6.14829 -6.04294
Net Income After Taxes -5.55887 -5.59137 -13.2327 -6.14829 -6.04294
Net Income Before Extra. Items -5.55887 -5.59137 -13.2327 -6.14829 -6.04294
Net Income -5.55887 -5.59137 -13.2327 -6.14829 -6.04294
Income Available to Common Excl. Extra. Items -5.55887 -5.59137 -13.2327 -6.14829 -6.04294
Income Available to Common Incl. Extra. Items -5.55887 -5.59137 -13.2327 -6.14829 -6.04294
Diluted Net Income -5.55887 -5.59137 -13.2327 -6.14829 -6.04294
Diluted Weighted Average Shares 9.13657 8.28148 8.70611 7.09874 6.98197
Diluted EPS Excluding Extraordinary Items -0.60842 -0.67516 -1.51993 -0.86611 -0.86551
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.57239 -0.67516 0.01534 -0.86611 -0.86551
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 37.1547 51.9456 18.8249 16.2352 28.1311
Cash and Short Term Investments 34.2473 49.3894 17.1642 14.8612 27.6115
Cash & Equivalents 11.4928 19.5863 17.1642 6.87527 13.3535
Short Term Investments 22.7545 29.8031 0 7.98589 14.258
Total Receivables, Net 0.12893 0.10884 0 0.02137 0.06831
Prepaid Expenses 2.77843 2.44741 1.6607 1.35267 0.45129
Total Assets 43.9759 74.0468 37.5273 38.2784 46.8556
Property/Plant/Equipment, Total - Net 0.70418 1.16801 1.34189 1.837 0.18463
Goodwill, Net 0 1.9761 1.9761 1.9761
Intangibles, Net 0 13.3662 13.4799 16.0775 16.3048
Other Long Term Assets, Total 1.61703 1.56694 1.90458 2.1526 0.25893
Total Current Liabilities 10.0371 6.76966 6.75346 7.89446 6.10654
Payable/Accrued
Accrued Expenses 5.02569 3.72241 2.89195 2.69128 2.5859
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.5 0.5 0.5 0.5
Total Liabilities 14.648 18.2509 18.9163 23.7193 25.9945
Total Long Term Debt 4.61095 5.85446 3.9345 7.96345 9.41704
Other Liabilities, Total 0 5.62675 8.22831 7.86143 10.4709
Total Equity 29.3279 55.7959 18.6111 14.559 20.8611
Common Stock 0.07436 0.05771 0.40701 0.23256 0.18832
Additional Paid-In Capital 397.98 388.601 330.29 304.886 294.393
Retained Earnings (Accumulated Deficit) -368.668 -332.77 -312 -290.517 -273.665
Treasury Stock - Common -0.08519 -0.08519 -0.08519 -0.08519 -0.08519
Other Equity, Total 0.02649 -0.00797 0 0.04278 0.02987
Total Liabilities & Shareholders’ Equity 43.9759 74.0468 37.5273 38.2784 46.8556
Total Common Shares Outstanding 7.4362 5.77052 2.71354 1.55047 1.25552
Property/Plant/Equipment, Total - Gross 3.34794 4.52374 4.56847 4.93368 3.15289
Accumulated Depreciation, Total -2.64376 -3.35574 -3.22659 -3.09668 -2.96826
Accounts Payable 3.58662 2.54725 2.24485 2.86295 3.02064
Long Term Debt 4.61095 5.85446 3.9345 7.96345 9.41704
Current Port. of LT Debt/Capital Leases 1.42477 0 1.11666 1.84023
Long Term Investments 4.5 6
Preferred Stock - Non Redeemable, Net 0 0
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 21.7255 26.732 36.3322 37.1547 40.1938
Cash and Short Term Investments 19.3769 24.0114 33.4263 34.2473 37.3525
Cash & Equivalents 12.8842 6.61136 10.4008 11.4928 26.9381
Short Term Investments 6.49268 17.4 23.0254 22.7545 10.4144
Total Receivables, Net 0.0971 0.08049 0.11636 0.12893 0.0305
Prepaid Expenses 2.25148 2.64008 2.78964 2.77843 2.81079
Total Assets 24.6544 28.7217 42.1062 43.9759 60.5311
Property/Plant/Equipment, Total - Net 2.48754 1.93974 1.97395 0.70418 0.87735
Property/Plant/Equipment, Total - Gross 3.19206
Accumulated Depreciation, Total -2.64376
Goodwill, Net
Intangibles, Net 0 13.3662
Long Term Investments 0 0 3.75 4.5 6
Other Long Term Assets, Total 0.44144 0.05 0.05 1.61703 0.09376
Total Current Liabilities 5.31651 6.12404 10.4183 10.0371 8.46451
Accounts Payable 1.82676 2.61244 3.97334 3.58662 3.36991
Accrued Expenses 3.48975 3.5116 4.26361 5.02569 4.29909
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 2.1813 1.42477 0.67051
Other Current Liabilities, Total 0 0.125
Total Liabilities 6.58269 7.20655 15.4592 14.648 19.18
Total Long Term Debt 0 0 3.89912 4.61095 5.31952
Long Term Debt 0 0 3.89912 4.61095 5.31952
Other Liabilities, Total 1.26618 1.08251 1.14188 0 5.396
Total Equity 18.0717 21.5151 26.647 29.3279 41.3511
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.09368 0.09252 0.09097 0.07436 0.07099
Additional Paid-In Capital 401.337 401.164 400.776 397.98 396.826
Retained Earnings (Accumulated Deficit) -383.295 -379.818 -374.259 -368.668 -355.435
Treasury Stock - Common -0.08519 -0.08519 -0.08519 -0.08519 -0.08519
Other Equity, Total 0.02044 0.16205 0.12388 0.02649 -0.02542
Total Liabilities & Shareholders’ Equity 24.6544 28.7217 42.1062 43.9759 60.5311
Total Common Shares Outstanding 9.36791 9.25198 9.09701 7.4362 7.09874
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -35.8982 -20.7693 -21.4836 -16.8515 -11.8834
Cash From Operating Activities -23.1314 -16.2236 -15.6187 -20.259 -7.04169
Cash From Operating Activities 0.73163 0.70292 0.74152 0.72167 0.35686
Non-Cash Items 10.3245 3.74225 5.53559 -0.56464 5.19025
Cash Taxes Paid 0 10.4191
Cash Interest Paid 4.84736 0.35728 0.84428 0.76062 0.51287
Changes in Working Capital 1.7107 -0.3619 -0.38573 -1.74515 -0.70543
Cash From Investing Activities 8.31528 -30.1227 7.92402 5.93586 -1.63234
Capital Expenditures -0.2678 -0.31161 -0.01909 -0.34916 -0.1384
Other Investing Cash Flow Items, Total 8.58308 -29.8111 7.94311 6.28502 -1.49394
Cash From Financing Activities 6.72267 54.7684 17.9836 7.84485 10.5835
Issuance (Retirement) of Stock, Net 6.72267 54.2023 23.1836 7.84485 0.85852
Issuance (Retirement) of Debt, Net 0 0.56604 -5.2 0 9.725
Net Change in Cash -8.09343 8.4221 10.2889 -6.47827 1.90949
Deferred Taxes 0 0.46238 -0.0265 -1.81932
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -5.59137 -35.8982 -22.6656 -16.5173 -10.4743
Cash From Operating Activities -4.08568 -23.1314 -18.0719 -13.387 -7.97652
Cash From Operating Activities 0.19268 0.73163 0.51355 0.34195 0.17399
Deferred Taxes 1.56703 0 1.38345 1.38345 1.38345
Non-Cash Items 0.3834 10.3245 1.72338 1.32715 0.91493
Cash Interest Paid 0.11246 4.84736 4.74273 4.26711 4.21186
Changes in Working Capital -0.63742 1.7107 0.9733 0.07767 0.02545
Cash From Investing Activities 0.51929 8.31528 19.1484 14.2035 16.7524
Capital Expenditures -0.05714 -0.2678 -0.22289 -0.16602 -0.05589
Other Investing Cash Flow Items, Total 0.57643 8.58308 19.3713 14.3696 16.8083
Cash From Financing Activities 2.47436 6.72267 6.27535 6.33937 0
Issuance (Retirement) of Stock, Net 2.47436 6.72267 6.27535 6.33937 0
Issuance (Retirement) of Debt, Net 0 0 0 0
Net Change in Cash -1.09203 -8.09343 7.35182 7.15586 8.77587

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Imunon Inc Company profile

Imunon Inc
Industry: Bio Therapeutic Drugs

997 Lenox Dr Ste 100
LAWRENCEVILLE
NEW JERSEY 08648
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.63 Price
-1.420% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,543.77 Price
-0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

69,988.60 Price
-1.120% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading